StonvexLoading…
StonvexStonvexStonvexCore line items from KYNB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.74M | $6.44M | $5.16M | $4.09M |
Operating Income | $-13.82M | $-45.90M | $-32.38M | $-26.97M |
Net Income | $-15.20M | $183.45M | $197.67M | $-2.96M |
EPS (Diluted) | $-3.76 | $45.37 | $48.90 | $-0.73 |
Total Assets | $109.63M | $119.59M | $137.01M | $178.06M |
Total Liabilities | $118.92M | $115.12M | $119.53M | $359.08M |
Cash & Equivalents | $37.00M | $47.87M | $117.97M | $23.37M |
Free Cash Flow OCF − CapEx | $-13.89M | $-4.81M | $13.52M | $15.37M |
Shares Outstanding | 4.05M | 4.05M | 4.04M | 4.04M |